We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Assertio Holdings Inc (NASDAQ:ASRT) exceeded $60 million in Rovedon sales, growing their share in the community oncology clinic segment. The company completed and presented the Rovedon same-day ...

Assertio (ASRT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.11 per share a year ago. These figures are ...

Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2024 Earnings Call Transcript ... to discuss Assertio's fourth quarter and full year 2024 financials. The news release covering our results for this ...

Assertio (NASDAQ:ASRT – Free Report ... and acute painful shoulder and gouty arthritis. Receive News & Ratings for Assertio Daily - Enter your email address below to receive a concise daily ...

Assertio Holdings (NASDAQ:ASRT) just reported results for the first quarter of 2024. Assertio Holdings reported earnings per share of 4 cents. This was above the analyst estimate for EPS of -3 cents.

Assertio Holdings Inc (NASDAQ:ASRT) exceeded $60 million in Rovedon sales, growing their share in the community oncology clinic segment. The company completed and presented the Rovedon same-day dosing ...